CME/CE

Use the tool below to view all available Global Kidney Academy Series

The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
MinuteCE®
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
1.00 program credit
Unmasking IgAN: Achieving Earlier Diagnosis
Unmasking IgAN: Achieving Earlier Diagnosis
MinuteCE®
Unmasking IgAN: Achieving Earlier Diagnosis
Jonathan Barratt, MD, PhD; An De Vriese, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
- An De Vriese, MD, PhD
1.00 program credit
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
MinuteCE®
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Jörg Latus, MD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- Jörg Latus, MD
1.00 program credit
The Future of IgAN Care
The Future of IgAN Care
MinuteCE®
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD; An De Vriese, MD, PhD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- An De Vriese, MD, PhD
- Jörg Latus, MD
1.00 program credit
The Evolving Role of Biomarkers in IgAN
The Evolving Role of Biomarkers in IgAN
MinuteCE®
The Evolving Role of Biomarkers in IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
1.00 program credit
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
CKD-aP Uncovered Prevalence & Pathophysiology
CKD-aP Uncovered Prevalence & Pathophysiology
MinuteCE®
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Spotlight on Assessment: Tools That Capture CKD-aP
Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
MinuteCE®
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Winning the CKD-aP Battle: A United Physician-Nurse Front
Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®
Winning the CKD-aP Battle: A United Physician-Nurse Front
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CE
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Inside the IgAN Clinic: Shared Decision-Making Into Practice
CME/CE
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
0.25 credits
- Jonathan Barratt, MD, PhD
0.25 credits
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits

CME/CE

Popular

Title

Welcome to Global Kidney Academy

Welcome to Global
Kidney Academy